Medical management

1) JointHealth Medications Guide

2) Arthritis Consumer Experts: JointHealth Education online course: JHEd: Advanced Therapies

3) Arthritis Consumer Experts: Biosimilars•Exchange

4) Arthritis Consumer Experts: Biosimilars Education Videos

5) EULAR: Recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

6) ACR: 2012 Update of the 2008 American College of Rheumatology (ACR) Recommendations for the use of Disease-Modifying Anti-Rheumatic Drugs and Biologics in the treatment of Rheumatoid Arthritis (RA)

7) EULAR: “Low-dose glucocorticoids are safe to use in early rheumatoid arthritis”

8) EULAR: “Managing the use of glucocorticoid therapy in rheumatic disease”

9) EULAR: “Biologics should be compared to the highest possible dose of methotrexate”

10) EULAR: “Newly updated advice on using DMARDs for RA”

11) EULAR: “Recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis”

12) European Medicines Agency: “Biosimilars Medicines”

13) European Medicines Agency and European Commission: “Biosimilars medicines animated video for patients”

14) European Commission: “Biosimilars information guide for patients”

15) “Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region”

16) “Inequities in access to biologic and synthetic DMARDs across 46 European countries”

 

Translate »